HCW Biologics Inc.
HCWB
$6.02
$0.132.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 70.29% | 9.63% | -20.12% | -89.19% | -105.09% |
| Total Depreciation and Amortization | 64.43% | 25.92% | 4.33% | -30.79% | -8.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.55% | -80.45% | -83.16% | 793.41% | 613.18% |
| Change in Net Operating Assets | -115.23% | 457.92% | 392.98% | 434.59% | 678.99% |
| Cash from Operations | 30.04% | 37.11% | 36.81% | 31.78% | 6.19% |
| Capital Expenditure | 96.62% | 97.81% | 95.78% | -51.19% | 63.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -41.12% |
| Cash from Investing | -102.72% | -103.32% | -106.89% | -151.90% | 13.40% |
| Total Debt Issued | -9.32% | 194.57% | -- | -- | -42.62% |
| Total Debt Repaid | -27.70% | -79.71% | -211.75% | -1,207.78% | -- |
| Issuance of Common Stock | 385.52% | 174.17% | 39,651.05% | 16,134.19% | 14,615.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 128.55% | 168.49% | 106,733.56% | 22,935.29% | -2.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.32% | 79.19% | 105.76% | 31.86% | 21.12% |